ZeClinics - Powering Discovery with Zebrafish

Zebrafish-expert CRO tailoring solutions for understanding human disease and performing drug and target discovery.

ZeClinics expertise in CRISPR genome editing allows developing custom zebrafish genetic models to mimic human disease and addressing the biomedical relevance of candidate compounds and genes in vivo. Zebrafish bridges the gap between cell and rodent experimental models, enabling accelerated and cost-effective drug and target discovery.

Our zebrafish models are contributing to the successful research at:

Our team

ZeClinics works alongside you from the start, with our scientific experts guiding you through every step—from design and execution to reporting—ensuring you're confident when presenting results to stakeholders.

Explore our services

As zebrafish experts, we leverage the unique advantages of this model to test multiple drugs and dosages in parallel, both at the tissue-specific and whole-organism levels. Thanks to their strong genomic and physiological similarities to humans, zebrafish provide valuable insights into organ function, disease mechanisms, and drug responses.

At ZeClinics, we specialize in zebrafish-based research to accelerate drug discovery while promoting ethical science. Reducing the use of mammals in experimentation isn’t just a regulatory goal—it’s a commitment we share with you, your company, and society.

Proudly supported by:

If you're involved in biomedical research, discover how ZeClinics' zebrafish expertise can transform your early-stage drug discovery process. LEARN MORE

SCIENCE |

ZebraReg—a novel platform for discovering regulators of cardiac regeneration using zebrafish

A powerful tool poised to streamline the target validation of novel gene regulators for regeneration and unlock new drug therapies aimed at heart regeneration post-myocardial infarction.


VIEW ALL SCIENCE

NEWS |

ZeClinics to Attend Neuroscience 2024: A Premier Neuroscience Event

Discover the Future of Neuroscience Research with Zebrafish at Our Booth #454


VIEW ALL NEWS

BLOG |

Hit-to-Lead Optimization with Zebrafish: Enhancing Early Drug Development


BLOG |

Understanding Zebrafish Development


VIEW ALL BLOG

ZeClinics redefines early drug discovery by bridging the gap between speed and translational relevance, eliminating the traditional trade-off between rapid screening and predictive power. Discover how we can accelerate your drug discovery process. GET IN CONTACT